Sight Sciences, Inc.

US$10.08As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SGHTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (21.84%)
Div yield —
ROE (50.07%)
Medical Devices
Beta (5Y) 2.40
PE TTM —
TSR TTM 99.21%
Mkt cap US$560.2M
ROIC (11.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.58
(4.92%)
44.37%
Sell 3|2|8|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.16
0.16
0.16
2.80%
15.99%
10.83%
8.91%
Revenue$M
56.13
56.10
58.87
58.19
(1.76%)
(1.50%)
6.41%
8.21%
Peers (US$560.2M)
Cap (US$)
PE
583.1M
25.23x
518.1M
1,016x
Capital
TTM
5Y
10Y
Leveragex
0.271
0.457
0.353
EBIT/Intx
0.101
0.811
0.747
Own earn%
378.86
(61.38)
(52.79)
Sh yield%
23.91
44.81
40.85
Owners
Insiders/Inst%
6.97
57.72
Short interest%
2.69
SBC / revenue%
2.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
1